NO850920L - Fremgangsmaate for fremstilling av fenyl-alkankarboksylsyrederivater - Google Patents
Fremgangsmaate for fremstilling av fenyl-alkankarboksylsyrederivaterInfo
- Publication number
- NO850920L NO850920L NO850920A NO850920A NO850920L NO 850920 L NO850920 L NO 850920L NO 850920 A NO850920 A NO 850920A NO 850920 A NO850920 A NO 850920A NO 850920 L NO850920 L NO 850920L
- Authority
- NO
- Norway
- Prior art keywords
- phenyl
- alkyl
- preparation
- acid derivatives
- halogen atom
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 4
- 238000002360 preparation method Methods 0.000 title claims description 3
- 150000001732 carboxylic acid derivatives Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims description 22
- 125000000217 alkyl group Chemical group 0.000 claims description 6
- 125000005843 halogen group Chemical group 0.000 claims description 6
- 229910052783 alkali metal Inorganic materials 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 4
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 4
- -1 2-hydroxy-phenyl Chemical group 0.000 claims description 3
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 claims description 2
- 150000001408 amides Chemical class 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 235000013312 flour Nutrition 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 241000700159 Rattus Species 0.000 description 5
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 230000011514 reflex Effects 0.000 description 3
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 2
- KPYSYYIEGFHWSV-UHFFFAOYSA-N Baclofen Chemical compound OC(=O)CC(CN)C1=CC=C(Cl)C=C1 KPYSYYIEGFHWSV-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- 239000003158 myorelaxant agent Substances 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- AQVQBKUTLFBTFJ-UHFFFAOYSA-N (5-chloro-2-hydroxy-3-propylphenyl)-(4-methylphenyl)methanone Chemical compound CCCC1=CC(Cl)=CC(C(=O)C=2C=CC(C)=CC=2)=C1O AQVQBKUTLFBTFJ-UHFFFAOYSA-N 0.000 description 1
- QCVSDCHNBNFJDQ-UHFFFAOYSA-N 1-(4-chloro-2-hydroxyphenyl)ethanone Chemical compound CC(=O)C1=CC=C(Cl)C=C1O QCVSDCHNBNFJDQ-UHFFFAOYSA-N 0.000 description 1
- 125000000590 4-methylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 231100000111 LD50 Toxicity 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 210000001361 achilles tendon Anatomy 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 1
- 229960002327 chloral hydrate Drugs 0.000 description 1
- 230000009194 climbing Effects 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000001670 myorelaxant effect Effects 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000001148 spastic effect Effects 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Physical Education & Sports Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8403686A FR2560871B1 (fr) | 1984-03-09 | 1984-03-09 | Derives d'acides o-((hydroxy-2 phenyl) methylene-amino)-phenyl-alcanecarboxyliques, leur preparation et leur application en therapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO850920L true NO850920L (no) | 1985-09-10 |
Family
ID=9301886
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO850920A NO850920L (no) | 1984-03-09 | 1985-03-08 | Fremgangsmaate for fremstilling av fenyl-alkankarboksylsyrederivater |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0160582A1 (fi) |
| JP (1) | JPS60204751A (fi) |
| AU (1) | AU3966385A (fi) |
| DK (1) | DK107385A (fi) |
| ES (1) | ES541079A0 (fi) |
| FI (1) | FI850923L (fi) |
| FR (1) | FR2560871B1 (fi) |
| GR (1) | GR850593B (fi) |
| HU (1) | HUT37391A (fi) |
| IL (1) | IL74513A0 (fi) |
| NO (1) | NO850920L (fi) |
| PT (1) | PT80082B (fi) |
| ZA (1) | ZA851772B (fi) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7186855B2 (en) | 2001-06-11 | 2007-03-06 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
-
1984
- 1984-03-09 FR FR8403686A patent/FR2560871B1/fr not_active Expired
-
1985
- 1985-02-26 EP EP85400352A patent/EP0160582A1/fr not_active Withdrawn
- 1985-03-06 IL IL74513A patent/IL74513A0/xx unknown
- 1985-03-08 AU AU39663/85A patent/AU3966385A/en not_active Abandoned
- 1985-03-08 JP JP60047318A patent/JPS60204751A/ja active Pending
- 1985-03-08 HU HU85876A patent/HUT37391A/hu unknown
- 1985-03-08 NO NO850920A patent/NO850920L/no unknown
- 1985-03-08 ZA ZA851772A patent/ZA851772B/xx unknown
- 1985-03-08 PT PT80082A patent/PT80082B/pt unknown
- 1985-03-08 GR GR850593A patent/GR850593B/el unknown
- 1985-03-08 FI FI850923A patent/FI850923L/fi not_active Application Discontinuation
- 1985-03-08 ES ES541079A patent/ES541079A0/es active Granted
- 1985-03-08 DK DK107385A patent/DK107385A/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| FR2560871B1 (fr) | 1986-10-10 |
| PT80082B (fr) | 1987-02-23 |
| EP0160582A1 (fr) | 1985-11-06 |
| JPS60204751A (ja) | 1985-10-16 |
| FI850923A0 (fi) | 1985-03-08 |
| DK107385D0 (da) | 1985-03-08 |
| IL74513A0 (en) | 1985-06-30 |
| FI850923L (fi) | 1985-09-10 |
| AU3966385A (en) | 1985-09-12 |
| HUT37391A (en) | 1985-12-28 |
| GR850593B (fi) | 1985-07-08 |
| ES8602620A1 (es) | 1985-12-01 |
| ZA851772B (en) | 1985-10-30 |
| PT80082A (fr) | 1985-04-01 |
| DK107385A (da) | 1985-09-10 |
| FR2560871A1 (fr) | 1985-09-13 |
| ES541079A0 (es) | 1985-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3885889T2 (de) | (r)5-pentylamino-5-oxopentanesäure-derivate mit anticholecystokininwirkung. | |
| CH624935A5 (fi) | ||
| EP0051301A1 (de) | 1-Carboxy-azaalkanoylindolin-2-carbonsäuren, Verfahren zu ihrer Herstellung, pharmazeutische Präparate enthaltend diese Verbindungen, sowie ihre therapeutische Verwendung | |
| US5480884A (en) | Compounds having a guanidine structure | |
| EP0435749A1 (fr) | Dérivés de 2-aminopyrimidine-4-carboxamide, leur préparation et leur application en thérapeutique | |
| DE19602969A1 (de) | Neue Morphinderivate, Verfahren zu deren Herstellung und deren Verwendung | |
| DE2310031A1 (de) | Substituierte 1-benzyl-indazol-3carbonsaeuren | |
| DE69406853T2 (de) | Alpha Aminosäurederivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen | |
| EP0001115A2 (de) | 2-Bromergosin und seine Säureadditionssalze, Verfahren zu deren Herstellung sowie deren Verwendung als Heilmittel | |
| DE2461802A1 (de) | Pyrazinderivate | |
| EP0105131B1 (en) | 2-(omega-alkylaminoalkyl)- and 2-(omega-dialkylaminoalkyl)-3-(4-x-benzylidene)-phthalimidines | |
| NO850920L (no) | Fremgangsmaate for fremstilling av fenyl-alkankarboksylsyrederivater | |
| NO794272L (no) | Fremgangsmaate for fremstilling av nye organiske forbindelser | |
| EP0233483B1 (de) | Pyrrolo[1,2-a][4,1]benzoxazepine, Verfahren zur ihrer Herstellung, pharmazeutische Präparate enthaltend diese Verbindungen, sowie therapeutische Verwendung | |
| DE2044172A1 (de) | Neue Pyrroldenvate, ein Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimittelzubereitungen | |
| DE2647041A1 (de) | 3-aminomethylen-6,7-dimethoxy-2- methyl-4-oxo-1,2,3,4-tetrahydro-1- chinolincarbonsaeureester und zwischenprodukte zur herstellung derselben | |
| NO162017B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive alfa-aryl-alfa-pyridylalkansyrederivater. | |
| DE2656678C2 (de) | 4-Amino-trans-decahydrochinolin-Derivate und Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen | |
| FI76788C (fi) | Foerfarande foer framstaellning av farmakologiskt vaerdefull 2-isopropylamino-pyrimidin-n-oxid. | |
| DE2654888A1 (de) | Diphenylacetamide, verfahren zu ihrer herstellung und sie enthaltende arzneimittel | |
| DE2308064C3 (de) | Benzotriazole, ihre Salze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| DE1695744B2 (de) | Derivate | |
| DE2921978A1 (de) | 3-amino-2-(5-fluoro- und 5-methoxy-1 h-indol-3-yl)-propansaeurederivate und arzneimittel, welche diese enthalten und verfahren zur herstellung der neuen verbindungen | |
| DE1795713C3 (de) | a-Aminobenzylpenicillinsäureester | |
| SU1069626A3 (ru) | Способ получени 3 @ ,4, @ 5 @ -триметоксиьензоата производных аповинкаминола или их солей |